+61 2 9812 3709 reception@mqrs.com.au

Research & Teaching

The physicians at Macquarie Respiratory and Sleep are extensively involved in internationally recognised research, and are world renowned in a number of areas.


We publish extensively in high impact peer reviewed journals, and present regularly at national and international scientific meetings. Many of us are also involved on the editorial boards of major journals, and actively contribute or lead consensus statements and documents on guidelines of management of many common respiratory issues and diseases. This include tobacco control, lung cancer, asthma, and chronic obstructive pulmonary  disease. Our physicians have also been at the forefront of designing and implementing national standards for recognition of competence for common thoracic procedures such as ultrasound and bronchoscopy.

We also supervise and mentor young researchers, providing opportunities for both laboratory and clinical research into areas such as new therapies in Interventional Pulmonology, Airways diseases including Asthma and COPD, Bronchiectasis, Interstitial Lung Disease and Sleep Medicine. We are currently supervising over 8 PhD students, and are also supervising Fellows and Registrars, as well as MD Research Projects for medical students.

We include some of our publications over the last 3 years: 

  1. Lilburn P, Tillekeratne N, Williamson JPhillips M, Ing AJ, Saghaie T. Tracheobronchial Stents: An Expanding Prospect. Int Med J 2023: In Press
  2. Hatch M, Lilburn P, Scott C, Ing AJ, Langton D. Safety and Efficacy of Bronchial Thermoplasty in Australia 5 years post-procedure. Respirology 2023 Aug 7.

    doi: 10.1111/resp.14568

  3. Lee AL, Smith R, Burr L, Chang AB, Holmes-Liew CL, King P, Morgan L, et al. ‘Teach me how to look after myself’: What people with bronchiectasis want from education in a pulmonary rehabilitation setting. Clin Respir J. 2023;17(1):59-69.
  4. Kumari S, Karikios D, Yeghiaian-Alvandi R, Flynn P, Morgan L, et al. Treatment patterns and long-term survival outcomes for patients with stage III non-small cell lung cancer: A retrospective study. Asia-Pac J Clin Oncol. 2023.
  5. Kirwin B, Saghaie T, Ing AJ, Hasovits C, Marx G. Cyclophosamide induced pneumonitis in patients receiving chemotherapy for early breast cancer. A case series and review of the literature. doi: 10.2241/au.168252551.18722805/v1
  6. Valipour A, Fernandez-Bussy S, Steinfort D, Ing AJ, Vanderlaan P. Bronchial Rheoplasty reduces goblet cell hyperplasia and airways inflammation in patients with chronic bronchitis. Am J Respir Crit Care Med May 2023: https://10.1164/ajrccm
  7. Lilburn P, Kwan J, Williamson J, Ho-Shon K, Azari M, Wilson M. Ing AJ, Saghaie T. Endobronchial indocyanine green instillation to identify the intersegmental plane for successful segmentectomy. Respirology Case Reports 2023; https://doi.org/10.1002/rcr2.1174
  8. Mitchell AB, Glanville AR. The role of systemic steroids in lung transplant recipients with community-acquired respiratory viruses: Time for a moratorium, or not? Transpl Infect Dis. 2023 Sep 7:e14142. doi: 10.1111/tid.14142. Epub ahead of print. PMID: 37676748.
  9. Gottlieb J, Torres F, Haddad T, Dhillon G, Dilling DF, Knoop C, Rampolla R, Walia R, Ahya V, Kessler R, Budev M, Neurohr C, Glanville AR, Jordan R, Porter D, McKevitt M, German P, Guo Y, Chien JW, Watkins TR, Zamora MR. A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant. J Heart Lung Transplant. 2023 Jul;42(7):908-916. doi: 10.1016/j.healun.2023.01.013. Epub 2023 Feb 7. PMID: 36964084.
  10. Beeckmans H, Bos S, Vos R, Glanville AR. Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction. Clin Chest Med. 2023 Mar;44(1):137-157. doi: 10.1016/j.ccm.2022.10.011. PMID: 36774160.
  11. Thomas, D, McDonald, VM, Stevens, S, Harvey, ES, Baraket, M, Bardin, P, Bowden, JJ, Bowler, S, Chien, J, Chung, LP, Gillman, A, Hew, M, Hodge, S, James, A, Jenkins, C, Katelaris, CH, Katsoulotos, GP, Langton, D, Lee, J, Marks, G, Peters, M, Radhakrishna, N, Reynolds, PN, Rimmer, J, Sivakumaran, P, Upham, JW, Wark, P, Yang, IA & Gibson, PG.Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients. Allergy: European Journal of Allergy and Clinical Immunology 2023. https://doi.org/10.1111/all.15867
  12. Soremekun S, Heaney LG, Skinner D, Bulathsinhala L, Carter V, Chaudhry I, Hosseini N, Eleangovan N, Murray R, Tran TN, Emmanuel B, Garcia Gil E, Menzies-Gow A, Peters M, Lugogo N, Jones R, Price DB. Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study. Thorax. 2023 Jul;78(7):643-652
  13. Kritikos V, Harvey ES, Stevens S, Katelaris CH, Langton D, Rimmer J, Farah CS, Gillman A, Hew M, Radhakrishna N, Thomas D, Gibson PG; Australian Mepolizumab Registry Investigators. Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2023 Mar;11(3):885-895.e13. doi: 10.1016/j.jaip.2022.12.004. Epub 2022 Dec 23
  14. Pfeffer PE, Ali N, Murray R, Ulrik C, Tran TN, Maspero J, Peters M, et al. Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both. Allergy. 2023 Jul;78(7):1934-1948. doi: 10.1111/all.15711. Epub 2023 Mar 27.
  15. Chen W, Tran TN, Sadatsafavi M, Murray R, Peters M, et al. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry. J Allergy Clin Immunol Pract. 2023 Jun 8:S2213-2198(23)00643-8. doi: 10.1016/j.jaip.2023.05.044. Online ahead of print.
  16. Vertigan AE, Harvey ES, Beyene T, Van Buskirk J, Holliday EG, Bone SL, McDonald VM, Horvat JC, Murphy VE, Jensen ME, Morgan GG, Zosky GR, Peters M, Farah CS, et al. Impact of landscape fire smoke exposure on patients with Asthma with or without laryngeal hypersensitivity. J Allergy Clin Immunol Pract. 2023 Jun 15:S2213-2198(23)00657-8. doi: 10.1016/j.jaip.2023.06.015. Online ahead of print.
  17. Lam S, Bai C, Baldwin D, Chen Y, Connolly C, de Koning H, Heuvelmans MA, Hu P, Kazerooni EA, Lancaster HL, Langs G, McWilliams A, Osarogiagbon RU, Oudkerk M, Peters M, Robbins HA, Sahar L, Smith RA, Triphuridet N, Field J. Current and Future Perspectives on CT Screening for Lung Cancer: A Road Map for 2023-2027 from the IASLC. J Thorac Oncol. 2023 Jul 22:S1556-0864(23)00687-1. doi: 10.1016/j.jtho.2023.07.019.
  18. Seccombe LM, Heath D, Farah CS, Di Michiel JR, Veitch EM, Peters MJ. Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID-19 pneumonitis. Physiol Rep. 2023 Apr;11(7):e15660. doi: 10.14814/phy2.15660.
  19. Tomaszewski EL, Atkinson MJ, Janson C, Karlsson N, Make B, Price D, Reddel HK, Vogelmeier CF, Müllerová H, Jones PW; NOVELTY Scientific Community; NOVELTY study investigators. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD. Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6.
  20. Ing AJ, Saghaie T. Ultrathin bronchoscopy and cryobiopsy in diagnosing peripheral pulmonary lesions: Another tool in the toolbox. Respirology. 2022 Nov 1. doi: 10.1111/resp.14402.
  21. Ing AJ, Jayapadman A, Kim WV et al. Reversal of collateral ventilation using endoscopic polymer foam in COPD patients undergoing endoscopic lung volume reduction with endobronchial valves: A controlled parallel group trial. Respirology. 2022 Dec;27(12):1064-1072
  22. Herath S, Wong C, Dawkins P, …Ing AJ. Cryobiopsy with Radial-EBUS (Cryo-Radial) has comparable diagnostic yield with higher safety in comparison to CT- guided transthoracic biopsy for Peripheral Pulmonary Lesions. An Exploratory Randomised Study. June 2022 Internal Medicine Journal DOI: 10.1111/imj.15833
  23. Herath S, Bashirzadeh F, Mahajan H, Fielding D, Ing AJ. Using the GenCut core biopsy tool with the radial endobronchial ultrasound guide sheath enables a high‐quality histology sample capable of programmed cell death ligand 1 (PD‐L1) testing. Respirology Case reports. May 2022. DOI: 10.1002/rcr2.935
  24. Herath S, Mahajan H, Yap E, Ing AJ. Radial Endobronchial Ultrasound guided biopsy for lung lesions: Evaluating the role of the guide sheath size, addition of needle aspirate and multi-modal sampling, in improving the diagnostic yield: An Exploratory randomized study. J Comm Med Public Health Reports Mar 2022. DOI: 10.38207/JCMPHR/2022/FEB03020119
  25. Wang Y, Taylor SL, Choo JM, Papanicolas LE, Keating R, Hindmarsh K, et al. Carriage and Transmission of Macrolide Resistance Genes in Patients With Chronic Respiratory Conditions and Their Close Contacts. Chest. 2022;162(1):56-65.
  26. Tal-Singer R, Walsh L, Deuby T, Shaughnessy A, Hoth KF, Gascon V, et al. Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory disease. Thorax. 2022;77(10):1045-7.
  27. Ora L, Mannix J, Morgan L, Gregory L, Luck L, Wilkes L. Chronic obstructive pulmonary disease and advance care planning: A synthesis of qualitative literature on patients’ experiences. Chronic Illn. 2022;18(2):221-33.
  28. Henriette Zweijpfenning SM, Chiron R, Essink S, Schildkraut J, Akkerman OW, Aliberti S, et al. Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study. Chest. 2022;162(1):76-81.
  29. Halbeisen FS, Pedersen ESL, Goutaki M, Spycher BD, Amirav I, Boon M, et al. Lung function from school age to adulthood in primary ciliary dyskinesia. Eur Respir J. 2022;60(4).
  30. Gerhardy B, Comsa M, Tahir A, Lynch D, Polkinghorne A, Orde S, et al. The first Australian experience with ward-based continuous positive airway pressure for COVID-19 respiratory failure: a retrospective cohort study. Intern Med J. 2022;52(11):1986-90.
  31. Fabri L, Shanthikumar S, Tadd K, Morgan L, Schultz A, Robinson P. Fissure adjacent partial lobe atelectasis in primary ciliary dyskinesia. J Paediatr Child Health. 2022;58(4):683-6.
  32. Chang AB, Morgan LC, Duncan EL, Chatfield MD, Schultz A, Leo PJ, et al. Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial. BMJ Open Respir Res. 2022;9(1).
  33. Beyene, T., Harvey, E. S., Van Buskirk, J., McDonald, V. M., Jensen, M. E., Horvat, J. C., Morgan, G. G., Zosky, G. R., Jegasothy, E., Hanigan, I., Murphy, V. E., Holliday, E. G., Vertigan, A. E., Peters, M., Farah, C. S., Jenkins, C. R., Katelaris, C. H., Harrington, J., Langton, D., Bardin, P. & 7 others. ‘Breathing fire’: impact of prolonged bushfire smoke exposure in people with severe asthma , 16 Jun 2022, In: International Journal of Environmental Research and Public Health. 19, 12, p. 1-15 15 p., 7419
  34. Agustí A, Rapsomaniki E, Beasley R, Hughes R, Müllerová H, Papi A et al. Treatable traits in the NOVELTY study. Respirology. 2022 Nov;27(11):929-940.
  35. Golam SM, Janson C, Beasley R, FitzGerald JM, Harrison T, Chipps B et al. The burden of mild asthma: clinical burden and healthcare resource utilisation in the NOVELTY study. Respiratory Medicine. 2022 Aug;200:1-9. 106863
  36. Azzi E, Kritikos V, Peters M, Price D, Cvetkovski B, Alphonse PS et al. Perceptions, attitudes, and behaviors of short-acting beta2 agonist users: an Australian cross-sectional community pharmacy-based study. Journal of Asthma. 2022;59(1):178-188
  37. Osibogun O, Chapman S, Peters M, Bursac Z, Maziak W. E-cigarette transitions among US youth and adults: results from the Population Assessment of Tobacco and Health Study (2013-2018). Journal of Prevention. 2022 Jun;43(3):387-405
  38. Chen, W, Sadatsafavi, M, Tran, TN, Murray, RB, Wong, CBN, Ali, N, Ariti, C, Gil, EG, Newell, A, Alacqua, M, Al-Ahmad, M, Altraja, A, Al-Lehebi, R, Bhutani, M, Bjermer, L, Bjerrum, AS, Bourdin, A, Bulathsinhala, L, Von Bülow, A, Busby, J, Canonica, GW, Carter, V, Christoff, GC, Cosio, BG, Costello, RW, Fitzgerald, JM, Fonseca, JA, Ha Yoo, K, Heaney, LG, Heffler, E, Hew, M, Hilberg, O, Hoyte, F, Iwanaga, T, Jackson, DJ, Jones, RC, Koh, MS, Kuna, P, Larenas-Linnemann, D, Lehmann, S, Lehtimäki, LA, Lyu, J, Mahboub, B, Maspero, J, Menzies-Gow, AN, Sirena, C, Papadopoulos, N, Papaioannou, AI, De Llano, LP, Perng, DW, Peters, M, Pfeffer, PE, Porsbjerg, CM, Popov, TA, Rhee, CK, Salvi, S, Taillé, C, Taube, C, Torres-Duque, CA, Ulrik, CS, Won Ra, S, Wang, E, Wechsler, ME & Price, DB 2022, ‘Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy’, Journal of Asthma and Allergy, vol. 15, pp. 1491-1510.
  39. Oscillometry and Asthma Control in Patients With and Without Fixed Airflow Obstruction. Cottee AM, Seccombe LM, Thamrin C, King GG, Peters MJ, Farah CS. J Allergy Clin Immunol Pract. 2022 May;10(5):1260-1267.e1. doi: 10.1016/j.jaip.2021.12.026
  40. Soremekun S, Heaney LG, Skinner D, Bulathsinhala L, Carter V, Chaudhry I et al. Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study. Thorax. 2022 Aug 3. 217032.
  41. Golam SM, Janson C, Beasley R, FitzGerald JM, Harrison T, Chipps B et al. The burden of mild asthma: clinical burden and healthcare resource utilisation in the NOVELTY study. Respiratory Medicine. 2022 Aug;200:1-9. 106863
  42. Agustí A, Rapsomaniki E, Beasley R, Hughes R, Müllerová H, Papi A et al. Treatable traits in the NOVELTY study. Respirology. 2022 Nov;27(11):929-940.
  43. Glanville AR, Mitchell AB. New Tools for Old Problems: Gastroesophageal Reflux Disease and the Lung Allograft Microbiome. Am J Respir Crit Care Med. 2022 Dec 15;206(12):1444-1445. doi: 10.1164/rccm.202207-1446ED. PMID: 35925015; PMCID: PMC9757095.
  44. Glanville AR, Benden C, Bergeron A, Cheng GS, Gottlieb J, Lease ED, Perch M, Todd JL, Williams KM, Verleden GM. Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions. ERJ Open Res. 2022 Jul 25;8(3):00185-2022. doi: 10.1183/23120541.00185-2022. PMID: 35898810; PMCID: PMC9309343.
  45. Mitchell AB, Glanville AR. The pulmonary microbiome: recent advances in understanding its role in chronic lung allograft dysfunction. Curr Opin Organ Transplant. 2022 Jun 1;27(3):217-221. doi: 10.1097/MOT.0000000000000956. PMID: 35649112.
  46. Glanville AR. Editorial: Current opinion in organ transplantation: lung transplantation. Curr Opin Organ Transplant. 2022 Jun 1;27(3):167-168. doi: 10.1097/MOT.0000000000000985. PMID: 35649106.
  47. de Zwart A, Riezebos-Brilman A, Lunter G, Vonk J, Glanville AR, Gottlieb J, Permpalung N, Kerstjens H, Alffenaar JW, Verschuuren E. Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies. Clin Infect Dis. 2022 Jul 6;74(12):2252-2260. doi: 10.1093/cid/ciab969. PMID: 35022697; PMCID: PMC9258934.

  48. Carew A, Williamson JP, Philips MJ, Saghaie T, Garah, CS, Ing AJ. Interventional bronchoscopy for chronic obstructive pulmonary disease: more than a pipe dream. Med J Aus 2021: Med J Aust. 2021 Sep 20;215(6):280-285
  49. Niessen NM, Gibson PG, Baines KJ, Barker D, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Simpson JL, Fricker M. Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment. Allergy. 2021 Jul;76(7):2090-2101.
  50. Cottee AM, Seccombe LM, Thamrin C, Badal T, King GG, Peters MJ, Farah CS. Longitudinal monitoring of asthma in the clinic using respiratory oscillometry. Respirology. 2021 Jun;26(6):566-573.
  51. Peters MJ. Commitment to quit is essential for tobacco harm reduction. Respirology. 2021 Jul;26(7):638-640.
  52. Defining a severe asthma super-responder: findings from a Delphi Process. Upham, J. W., Le Lievre, C., Jackson, D. J., Masoli, M., Wechsler, M. E., Price, D. B. & the Delphi Panel, Nov 2021, In: Journal of Allergy and Clinical Immunology: In Practice. 9, 11, p. 3997-4004
  53. Lee H, Choi H, Chalmers JD, Dhar R, Nguyen TQ, Visser SK, Morgan L et al. Characteristics of bronchiectasis in Korea: First data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries. Respirology. 2021;26(6):619-21.
  54. Kapur N, Stroil-Salama E, Morgan L, Yerkovich S, Holmes-Liew CL, King P, et al. Factors associated with “Frequent Exacerbator” phenotype in children with bronchiectasis: The first report on children from the Australian Bronchiectasis Registry. Respir Med. 2021;188.
  55. Aliberti S, Lucy M. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. The Lancet Respiratory Medicine. 2021.
  56. Mitchell AB, Li CX, Oliver BGG, Holmes EC, Glanville AR. High-resolution Metatranscriptomic Characterization of the Pulmonary RNA Virome After Lung Transplantation. Transplantation. 2021 Dec 1;105(12):2546-2553. doi: 10.1097/TP.0000000000003713. PMID: 34793112.
  57. Crespo MM, Claridge T, Domsic RT, Hartwig M, Kukreja J, Stratton K, Chan KM, Molina M, Ging P, Cochrane A, Hoetzenecker K, Ahmad U, Kapnadak S, Timofte I, Verleden G, Lyu D, Quddus S, Davis N, Porteous M, Mallea J, Perch M, Distler O, Highland K, Magnusson J, Vos R, Glanville AR. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements. J Heart Lung Transplant. 2021 Nov;40(11):1279-1300. doi: 10.1016/j.healun.2021.07.013. Epub 2021 Jul 31. PMID: 34474940.
  58. Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, Campos SV, Christon LM, Cypel M, Dellgren G, Hartwig MG, Kapnadak SG, Kolaitis NA, Kotloff RM, Patterson CM, Shlobin OA, Smith PJ, Solé A, Solomon M, Weill D, Wijsenbeek MS, Willemse BWM, Arcasoy SM, Ramos KJ. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2021 Nov;40(11):1349-1379. doi: 10.1016/j.healun.2021.07.005. Epub 2021 Jul 24. PMID: 34419372; PMCID: PMC8979471.
  59. Crothers E, Kennedy DS, Emmanuel S, Molan N, Scott S, Rogers K, Glanville AR, Ntoumenopoulos G. Incidence of early diaphragmatic dysfunction after lung transplantation: results of a prospective observational study. Clin Transplant. 2021 Sep;35(9):e14409. doi: 10.1111/ctr.14409. Epub 2021 Jul 8. PMID: 34192380.
  60. Mitchell AB, Glanville AR. The Impact of Resistant Bacterial Pathogens including Pseudomonas aeruginosa and Burkholderia on Lung Transplant Outcomes. Semin Respir Crit Care Med. 2021 Jun;42(3):436-448. doi: 10.1055/s-0041-1728797. Epub 2021 May 24. PMID: 34030205.
  61. Glanville AR. Ureaplasma and Lung Transplantation: A Pinch of Prophylaxis May Mollify a Not-So-Cute Infection. Transplantation. 2021 Mar 1;105(3):480-481. doi: 10.1097/TP.0000000000003541. PMID: 33273322.
  62. Valipour A, Fernandez-Bussy S, Ing AJ, Steinfort DP, Snell GI, Williamson JP, Saghaie T, Irving LB, Dabscheck EJ, Krimsky WS, Waldstreicher J. Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 12 Month Results from a Multi-Center Study. Am J Respir Crit Care Med. 2020 May 14. doi: 10.1164/rccm.201908-1546OC
  63. Ing AJ, Hersch N, Sullivan C, Saghaie T, Williamson J. Reversal of Collateral Ventilation using endobronchial polymer sealant in a patient with emphysema undergoing Endoscopic Lung Volume Reduction (ELVR) with valves: a case report and proof of concept. J Bronchology Interv Pulmonol. 2020 Jan;27(1):e14-e16. doi: 10.1097/LBR.0000000000000634
  64. Shelley She, Daniel Steinfort, Paul Leong, Alvin Ing, Jonathan Williamson, Barton Jennings, Tajalli Saghaie. Transbronchial Cryobiopsy in interstitial lung disease diagnosis – a standardised protocol. J Bronchology Interv Pulmonol. 2020 Jan;27(1):36-41. doi: 10.1097/LBR.0000000000000633
  65. Goutaki M, Halbeisen FS, Barbato A, Crowley S, Harris A, Hirst RA, Morgan L et al. Late diagnosis of infants with PCD and neonatal respiratory distress. J Clin Med. 2020;9(9):2871.
  66. O’Neill C, Gibson PG, Heaney LG, Upham JW, Yang IA, Reynolds PN, Hodge S, Jenkins CR, Peters M, Marks GB, James AL, Simpson JL. The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma. Eur Respir J. 2020 Oct 2:2002436. doi: 10.1183/13993003.02436-2020.c
  67. McDonald CF, Jones S, Beckert L, Bonevski B, Buchanan T, Bozier J, Carson-Chahhoud KV, Chapman DG, Dobler CC, Foster JM, Hamor P, Hodge S, Holmes PW, Larcombe AN, Marshall HM, McCallum GB, Miller A, Pattemore P, Roseby R, See HV, Stone E, Thompson BR, Ween MP, Peters MJ. Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2020 Oct;25(10):1082-1089.
  68. Fitzgerald DA, Peters M. E-cigarettes, e-toxicity and e-commerce: a continuing public health emergency. Paediatric Respiratory Reviews. 2020 Nov 1;36:73-74. 
  69. Azzi E, Kritikos V, Peters M, Price D , Cvetkovski B, Alphonse PS & Bosnic-Anticevich S. Perceptions, attitudes, and behaviours of Short-acting Beta2 Agonist users: an Australian cross-sectional community pharmacy-based study. Journal of Asthma 2020 DOI: 10.1080/02770903.2020.1841223
  70. Acheson, L. S., Rogers, P. G., Thamrin, C., Peters, M. J., Farah, C. S. & Seccombe, L. M. Acute cardiopulmonary responses during expert trumpet performance. Respiratory Physiology and Neurobiology 2020; 281: 1-4.
  71. Dessaix A, Freeman B & Peters MJ. Making tobacco control a priority. Public Health Research and Practice 2020; 30: e3032015.
  72. Maltby S, McDonald VM, Upham JW, Bowler SD, Chung LP, Denton EJ, Fingleton J, Garrett J, Grainge CL, Hew M, James AL, Jenkins C, Katsoulotos G, King GG, Langton D, Marks GB, Menzies-Gow A, Niven RM, Peters M, Reddel HK, Thien F, Thomas PS, Wark PAB, Yap E, Gibson PG; Severe Asthma Expert Forum contributors. Severe Asthma Assessment, Management and the Organisation of Care in Australia and New Zealand: Expert Forum Roundtable Meetings. Intern Med J. 2020 Feb 27. doi: 10.1111/imj.14806.
  73. Cottee, A. M., Seccombe, L. M., Thamrin, C., King, G. G., Peters, M. J. & Farah, C. S. Response Chest 2020; 158, 1283-1284.
  74. Zimmermann, S. C., Huvanandana, J., Nguyen, C. D., Bertolin, A., Watts, J. C., Gobbi, A., Farah, C. S., Peters, M. J., Dellacà, R. L., King, G. G. & Thamrin, C. Day-to-day variability of forced oscillatory mechanics for early detection of acute exacerbations in COPD. Eur Resp J 2020; 56: 1-13. 
  75. FitzGerald, J. M., Tran, T. N., Alacqua, M., Altraja, A., Backer, V., Bjermer, L., Bjornsdottir, U., Bourdin, A., Brusselle, G., Bulathsinhala, L., Busby, J., Canonica, G. W., Carter, V., Chaudhry, I., Cho, Y. S., Christoff, G., Cosio, B. G., Costello, R. W., Eleangovan, N., Gibson, P. G. & 28 others, , International severe asthma registry (ISAR): protocol for a global registry. BMC Medical Research Methodology 2020; 20: 1-14.
  76. Peters, M. J., Electronic cigarettes: tumultuous times. Respirology 2020; 25: 570-571.
  77. Cottee, A. M., Seccombe, L. M., Thamrin, C., King, G. G., Peters, M. J. & Farah, C. S. Bronchodilator response assessed by the forced oscillation technique identifies poor asthma control with greater sensitivity than spirometry. Chest 2020; 157:1435-1441.
  78. Harvey, E. S., Langton, D., Katelaris, C., Stevens, S., Farah, C. S., Gillman, A., Harrington, J., Hew, M., Kritikos, V., Radhakrishna, N., Bardin, P., Peters, M., Reynolds, P. N., Upham, J. W., Baraket, M., Bowler, S., Bowden, J., Chien, J., Chung, L. P., Grainge, C. & 8 others. Mepolizumab effectiveness and identification of super-responders in severe asthma. European Respiratory Journal 2020; 55:1-13.
  79. Carson-Chahhoud, K. V., Smith, B. J., Peters, M. J., Brinn, M. P., Ameer, F., Singh, K., Fitridge, R., Koblar, S. A., Jannes, J., Veale, A. J., Goldsworthy, S., Hnin, K. & Esterman, A. J., Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): a randomized controlled clinical trial. PLoS ONE 2020; 15: 1-11.
  80. The ISAR Study Group. International Severe Asthma Registry: mission statement. Chest 2020; 157: 805-814.
  81. Wang, E., Wechsler, M. E., Tran, T. N., Heaney, L. G., Jones, R. C., Menzies-Gow, A. N., Busby, J., Jackson, D. J., Pfeffer, P. E., Rhee, C. K., Cho, Y. S., Canonica, G. W., Heffler, E., Gibson, P. G., Hew, M., Peters, M., Harvey, E. S., Alacqua, M., Zangrilli, J., Bulathsinhala, L., Carter, V. A., Chaudhry, I., Eleangovan, N., Hosseini, N., Murray, R. B., Price, D. B. Characterization of severe asthma worldwide: data from the International Severe Asthma Registry. Chest 2020; 157: 790-804.
  82. Kelleher AD, Cortez-Jugo C, Cavalieri F, Qu Y, Glanville AR, Caruso F, Symonds G, Ahlenstiel CL. RNAi therapeutics: an antiviral strategy for human infections. Curr Opin Pharmacol. 2020 Oct;54:121-129. doi: 10.1016/j.coph.2020.09.011. Epub 2020 Nov 7. PMID: 33171339.
  83. Glanville AR. Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction. Eur Respir J. 2020 Oct 1;56(4):2001968. doi: 10.1183/13993003.01968-2020. PMID: 33004442.
  84. De Rosa N, Paddon V, Glanville A, Parsi K. Dermatological Disease in Australian Heart and Lung Transplant Recipients. Dermatology. 2021;237(4):629-634. doi: 10.1159/000510055. Epub 2020 Sep 17. PMID: 32942278.
  85. Marriott D, Beresford R, Mirdad F, Stark D, Glanville A, Chapman S, Harkness J, Dore GJ, Andresen D, Matthews GV. Concomitant Marked Decline in Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses Among Symptomatic Patients Following Public Health Interventions in Australia: Data from St Vincent’s Hospital and Associated Screening Clinics, Sydney, NSW. Clin Infect Dis. 2021 May 18;72(10):e649-e651. doi: 10.1093/cid/ciaa1256. PMID: 32841316; PMCID: PMC7499558.
  86. Gaikwad AV, Eapen MS, McAlinden KD, Chia C, Larby J, Myers S, Dey S, Haug G, Markos J, Glanville AR, Sohal SS. Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis. Expert Rev Respir Med. 2020 Oct;14(10):1027-1043. doi: 10.1080/17476348.2020.1795832. Epub 2020 Jul 28. PMID: 32659128.